Actively Recruiting
Temporary Peripheral Nerve Stimulation for Moderate to Severe Knee Osteoarthritis Evaluating Genicular and Saphenous Nerve Treatment
Led by Tanta University · Updated on 2026-06-18
100
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the use of peripheral nerve stimulation PNS, a drug-free pain management technique, for people with moderate to severe knee pain caused by osteoarthritis. This study focuses on targeting specific nerves in the knee to block pain signals and reduce the perception of pain, offering an alternative to medications or invasive procedures. The primary goal is to assess changes in pain levels immediately after treatment using a visual analogue scale. The study compares two types of temporary transcutaneous nerve stimulation devices applied to different nerves the genicular nerve and the saphenous nerve. Each treatment involves delivering electrical impulses at 2Hz frequency, 0.2mA current, and 1ms pulse duration for 4 to 6 minutes. Participants are randomly assigned to one of these two treatment groups in a triple-blinded parallel trial design. The treatments are designed to be temporary and non-invasive. Participants will undergo the nerve stimulation procedure and have their pain levels measured immediately after intervention. Researchers will monitor the change in pain using a visual scale. The trial includes adults aged 30 to 70 years who have moderate to severe knee osteoarthritis and have not responded to certain medications or physical therapy. The total participation duration aligns with the treatment and immediate outcome measurement, with study completion expected in November 2026.
CONDITIONS
Brief Title
Percutaneous Neurostimulation in Knee Osteoarthritis
Research Team
A
Aliaa Mamdouh Abdelaziz Farag, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here